arrow_back Back to App

Support for Pediatric Disease Research and Young Scientists Development.

This act aims to accelerate pediatric disease research by funding promising scientists. This will help children receive new, effective therapies faster, and support young researchers in their scientific careers. It's a step towards better healthcare for the youngest.
Key points
New funding for pediatric disease research, including cancer, rare diseases, and children's mental health.
Support for early-career scientists, including physician-scientists, to conduct important research.
Establishment of a consortium to coordinate pediatric research for better collaboration and efficiency.
Prioritization of research involving historically underrepresented populations, such as women and racial minorities.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_4714
Sponsor: Rep. Joyce, John [R-PA-13]
Process start date: 2023-07-18
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Pediatricians Accelerate Childhood Therapies Act of 2023

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_4714.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-07-18.

What are the main provisions?

Key points include:

  • New funding for pediatric disease research, including cancer, rare diseases, and children's mental health.
  • Support for early-career scientists, including physician-scientists, to conduct important research.
  • Establishment of a consortium to coordinate pediatric research for better collaboration and efficiency.
  • Prioritization of research involving historically underrepresented populations, such as women and racial minorities.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Joyce, John [R-PA-13].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

CATEGORIES

Health